Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Urogen Pharma Ltd
(NQ:
URGN
)
16.20
+0.41 (+2.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Urogen Pharma Ltd
< Previous
1
2
3
4
Next >
UroGen Pharma to Host Virtual Spotlight Event on November 10, 2021
November 01, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
The Journal of Urology Publishes Results of UroGen Pharma’s Phase 2b Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)
October 05, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma to Present at the 2021 Cantor Virtual Global Healthcare Conference
September 23, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma Presents Data Showcasing Novel Clinical Data at 2021 American Urological Association (AUA) Annual Meeting
September 13, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 10, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 03, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma Reports Second Quarter 2021 Financial Results and Recent Corporate Developments
August 04, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma Announces License and Supply Agreement with Neopharm to Pursue Regulatory Approval and Commercialization for Jelmyto® in Israel
July 28, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma to Report Second Quarter 2021 Financial Results on Wednesday, August 4, 2021
July 28, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma Reports Strong Preliminary Jelmyto® Sales for Second Quarter 2021
July 14, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma to Present at Ladenburg Thalmann Healthcare Conference
July 07, 2021
From
UroGen Pharma Ltd
Via
Business Wire
UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma Announces June 2021 Conference Schedule
May 25, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma Reports First Quarter 2021 Financial Results and Recent Corporate Developments
May 13, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
May 06, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.